Multicenter Retrospective Analysis of Nivolumab Monotherapy Outcomes in Advanced Renal Cell Carcinoma by the Spanish Genitourinary Oncology Group
-
By
-
Natalia Fernández-Díaz
-
María Mateos-González
-
Ana Pertejo-Fernández
-
Juan Diego Cacho-Lavín
-
María José Juan-Fita
-
Isabel Chirivella-González
-
Mikel Arruti-Ibarbia
-
Ovidio Fernández-Calvo
-
Natalia Fernández-Núñez
-
María José Méndez-Vidal
-
Martín Lázaro-Quintela
-
Aurea Molina-Díaz
-
Nieves Del Pozo-Alonso
-
Olatz Etxaniz-Ulazia
-
Silvia Margarita García-Acuña
-
Yoel Z. Betancor
-
Ainara Azueta-Etxebarria
-
Ana Calatrava-Fons
-
Helena Lombardía-Rodríguez
-
Lorena Alarcón-Molero
-
Leire Etxegarai-Ganboa
-
Abraham Antón-Cameselle
-
José Antonio Bello-Giz
-
Carlos Manuel Neira-De Paz
-
Teresa Cabaleiro
-
Teresa González-Serrano
-
José Antonio Ortiz-Rey
-
Felipe Sacristán-Lista
-
Silvia García-Rubín
-
Elisa Ortega
-
Cristina Carrato-Moñino
-
Santiago Aguín-Losada
-
Luis León-Mateos
-
Jorge García-González
-
Álvaro Pinto-Marín
-
Ignacio Duran
-
Rafael López-López
-
Urbano Anido-Herranz
-
Juan Ruiz-Bañobre
-
November 28, 2025
-
0 min
Top Institutions in Oncology
Brief introduction explaining scope and methodology.
-
#1
Memorial Sloan Kettering Cancer Center
New York, NY
-
#2
Dana-Farber Cancer Institute
Boston, MA
-
#3
MD Anderson Cancer Center
Houston, TX
-
#4
Vall d'Hebron Institute of Oncology (VHIO)
Barcelona, Catalonia
-
#5
The University of Texas Southwestern Medical Center
Dallas, TX
